BlackRock Inc. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 145 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$280,091,012
-19.9%
6,090,259
+0.0%
0.01%
-20.0%
Q2 2023$349,890,407
+42.1%
6,088,227
-7.3%
0.01%
+42.9%
Q1 2023$246,265,353
+24.9%
6,567,076
-6.7%
0.01%
+16.7%
Q4 2022$197,226,307
-1.8%
7,038,769
-1.5%
0.01%
-14.3%
Q3 2022$200,854,000
-18.4%
7,147,813
+1.1%
0.01%
-12.5%
Q2 2022$246,042,000
-3.5%
7,072,197
-0.4%
0.01%
+14.3%
Q1 2022$255,016,000
+52.9%
7,103,524
-0.8%
0.01%
+75.0%
Q4 2021$166,771,000
+22.2%
7,160,665
-0.2%
0.00%0.0%
Q3 2021$136,446,000
-6.9%
7,177,581
-1.3%
0.00%0.0%
Q2 2021$146,557,000
+8.4%
7,269,619
-1.5%
0.00%0.0%
Q1 2021$135,150,000
-5.9%
7,377,178
+3.3%
0.00%
-20.0%
Q4 2020$143,669,000
+11.0%
7,144,166
+3.5%
0.01%0.0%
Q3 2020$129,439,000
-12.8%
6,903,389
+4.4%
0.01%
-16.7%
Q2 2020$148,505,000
+61.2%
6,611,928
+6.5%
0.01%
+20.0%
Q1 2020$92,115,000
-22.1%
6,207,165
+1.2%
0.01%0.0%
Q4 2019$118,287,000
-0.5%
6,132,054
+2.3%
0.01%0.0%
Q3 2019$118,897,000
-5.0%
5,995,824
+1.2%
0.01%0.0%
Q2 2019$125,124,000
+4.9%
5,927,141
+1.5%
0.01%0.0%
Q1 2019$119,312,000
+1.2%
5,840,034
-1.5%
0.01%
-16.7%
Q4 2018$117,946,000
+2.4%
5,926,878
-1.0%
0.01%
+20.0%
Q3 2018$115,205,000
+32.0%
5,987,805
+4.7%
0.01%
+25.0%
Q2 2018$87,291,000
-13.8%
5,720,183
+5.9%
0.00%
-20.0%
Q1 2018$101,284,000
-4.5%
5,401,823
-2.0%
0.01%0.0%
Q4 2017$106,106,000
+7.7%
5,514,765
+0.0%
0.01%0.0%
Q3 2017$98,508,000
+2.2%
5,512,455
+2.2%
0.01%0.0%
Q2 2017$96,355,000
+20.4%
5,394,972
-2.2%
0.01%
+25.0%
Q1 2017$80,026,000
+173869.6%
5,519,038
+224342.4%
0.00%
Q4 2016$46,000
-6.1%
2,459
-5.6%
0.00%
Q3 2016$49,000
+32.4%
2,605
+14.5%
0.00%
Q2 2016$37,000
-15.9%
2,276
-37.8%
0.00%
Q1 2016$44,000
+340.0%
3,658
+396.3%
0.00%
Q4 2015$10,000
+11.1%
7370.0%0.00%
Q3 2015$9,000
-30.8%
7370.0%0.00%
Q2 2015$13,0007370.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2021
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders